VanEck Avalanche ETF Reports Significant Asset Growth Despite NAV Decline

VanEck Avalanche ETF has reported significant financial developments in its latest 10-Q filing for the period ending June 30, 2026. The Trust's total assets surged to $11.57 million, a substantial increase from $2.52 million at the end of the previous fiscal period. This growth is primarily attributed to the Trust's investment in Avalanche (AVAX), which rose in fair value from $2.52 million to $11.57 million. However, the net asset value (NAV) per share decreased from $25.18 to $14.02, reflecting a 44.32% decline over the six-month period, largely due to a 45.17% drop in the price of AVAX.

In terms of operational performance, the Trust generated $130,811 in staking income for the three months ended June 30, 2026, and $185,683 for the six-month period. Total expenses for the same three-month period were reported at $11,852, leading to a net investment income of $118,959. Despite this income, the Trust experienced a net decrease in net assets of $3.92 million for the quarter, driven by a net realized loss and a significant unrealized depreciation of $4.04 million on its AVAX investments.

The Trust's share count increased dramatically, with 825,000 shares outstanding as of June 30, 2026, compared to just 100,000 shares at the end of December 2025. This increase was facilitated by the issuance of 725,000 shares over the six-month period, with no shares redeemed. The Trust's capital share transactions contributed to a net increase in net assets of $9.05 million for the six months, indicating strong investor interest despite the volatility in AVAX prices.

Looking ahead, the Trust's management has acknowledged the inherent risks associated with the digital asset market, particularly the volatility of AVAX. The regulatory landscape remains uncertain, which could impact the Trust's operations and the value of its shares. The management has indicated that future developments in regulations could significantly affect the Trust's ability to operate and the valuation of its assets. The Trust's investment strategy remains focused on tracking the performance of AVAX, and it will continue to monitor market conditions closely as it navigates these challenges.